We conducted a clustering analysis based on the 121 proteins, showing at least a two-fold difference when comparing AML cells and CD34+ bone marrow cells (Table S5), and this analysis identified a subset of 28 patients characterized by neutrophil differentiation and favorable prognosis (Table S7 for details). This evidence concerns the gene CD34 and acute myeloid leukemia.